Aerpace Industries allots 1.5 crore warrants to promoter group trust
- Aerpace Industries allotted 1.5 crore warrants to N.K. Family Private Trust
- Issue price fixed at ₹32.55 per warrant on a preferential basis
- Total aggregate value of the warrant issue stands at ₹48.82 crore
- Company received ₹12.20 crore upon the allotment of warrants

*this image is generated using AI for illustrative purposes only.
Aerpace Industries Limited has allotted 1.5 crore warrants to N.K. Family Private Trust, a member of the promoter group, on a preferential basis. The transaction aggregates to ₹48.82 crore, with the company receiving ₹12.20 crore upon allotment.
The Board of Directors approved the allotment of 1,50,00,000 warrants at an issue price of ₹32.55 per warrant. This move follows prior disclosures made on July 9, 2026, and August 8, 2026, which detailed the board's approval and subsequent shareholder ratification for the issuance.
Allotment Details
The company confirmed the receipt of funds corresponding to the allotted warrants. The regulatory filings highlight compliance with SEBI Listing Regulations regarding the disclosure of material events.
| Metric | Value |
|---|---|
| Warrants Allotted | 1,50,00,000 |
| Issue Price | ₹32.55 per warrant |
| Total Aggregate Value | ₹48.82 crore |
| Amount Received | ₹12.20 crore |
| Allottee | N.K. Family Private Trust |
Regulatory Compliance
Aerpace Industries stated that all requisite disclosures prescribed under the SEBI Master Circular dated January 30, 2026, were duly made in respect of the Board Meeting held on July 9, 2026. The allotment was executed following the receipt of ₹12.20 crore from the proposed allottee.
The filing was signed by Anand Manoj Shah, Managing Director and Chief Financial Officer, on September 27, 2026.
Historical Stock Returns for Aerpace Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.99% | +1.71% | +8.23% | +49.38% | +65.47% | +1,170.51% |
How will the remaining ₹36.62 crore be utilized, and what specific capital expenditure or debt reduction plans are tied to this preferential allotment?
What are the dilution implications for minority shareholders once these warrants are fully converted into equity shares?
Does this promoter-led infusion signal a strategic pivot or expansion plan for Aerpace Industries in the near term?


































